It is a pharma private limited company based in New Delhi, Delhi, India, established in 1993.
1993 | New Delhi, Delhi, India | ActiveShanti Drugs Private Limited, a active private limited company, was established on 15 January 1993 in New Delhi, Delhi, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U74899DL1993PTC051735. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.41 Cr.
It upholds a compliant status. Employing 5 professional, Its leadership includes Kamlesh Gupta (Director), Rakesh Gupta (Director), Om Prakash (Director). Past directors included Om Prakash, Ankit Gupta. It holds ₹3.20 M open charges and ₹2.20 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at D-23 Ground Floor South Extn Part-1, New Delhi, Delhi, 110049.
U74899DL1993PTC051735
051735
15 January 1993
₹1.50 Cr
₹1.41 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Shanti Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamlesh Gupta | Director | 01 Sep 2003 | Current |
| Rakesh Gupta | Director | 15 Jan 1993 | Current |
| Om Prakash | Director | 11 Sep 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shanti Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 31.96% decrease. The company also saw a substantial improvement in profitability, with a 1833.24% increase in profit. The company's net worth moved up by a moderate rise of 2.4%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Shanti Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹3,200,000.00
₹22,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Sep 2024 | Hdfc Bank Limited | ₹3.20 M | Open |
| 08 Jun 2010 | Delhi Nagrik Sehkari Bank Ltd. | ₹2.20 Cr | Satisfied |
Explore comprehensive loan charge details -
Shanti Drugs has a workforce of 5 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Shanti Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shanti Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Shanti Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 0.32 Cr with Charge ID 100995774 was registered on 12 Sep 2024. was recorded as a recent event.
Shanti Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Om Prakash was appointed as a Director was appointed as a Director on 11 Sep 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.
Progress on A charge registered on 08 Jun 2010 via Charge ID 10226292 with Delhi Nagrik Sehkari Bank Ltd. was fully satisfied on 05 May 2017. was documented.
A charge with Delhi Nagrik Sehkari Bank Ltd. amounted to Rs. 2.20 Cr with Charge ID 10226292 was registered on 08 Jun 2010. was recorded as a recent event.
The CIN of Shanti Drugs Private Limited is U74899DL1993PTC051735.
Shanti Drugs Private Limited is headquartered at D-23 Ground Floor South Extn Part-1, New Delhi, Delhi, 110049.
Shanti Drugs Private Limited was incorporated on 15 January 1993.
The current directors of Shanti Drugs Private Limited are
The primary industry of Shanti Drugs Private Limited is Manufacturing.
Shanti Drugs Private Limited is unlisted.
The authorized capital of Shanti Drugs Private Limited is ₹1.50 Cr, and the paid-up capital is ₹1.41 Cr.
The compliance status of Shanti Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX